SUBSCRIBE
IQVIA Blog Digest
For all the latest industry insights, please subscribe to the IQVIA U.S. blog digest.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
WHO WE HELP
-
Pharmaceutical Manufacturers
-
Emerging Biopharma
-
MedTech
-
Financial Institutions
-
Government and Public Health
-
Health Plans
-
Hospital and Health Systems
-
Insurers and Risk
-
Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers
Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MorePharmaceutical Manufacturers
Emerging Biopharma (Global page)
Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsMedTech
Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechMedTech
Financial Institutions
Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsGovernment and Public Health
Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsGovernment and Public Health
Health Plans
Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansHospital and Health Systems
Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsHospital and Health Systems
Insurers and Risk
Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover More
Medical Specialty and Patient Advocacy
Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.
Explore NowU.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSBlog
Focus on Patient Outcomes via Clinical Nurse Educators
Per-diem model is efficient, cost effective
Feb 03, 2021
Most people around the world are looking forward to changes following the COVID-19 crisis; nearly three-fourths of those surveyed in 28 countries do not want their daily lives to return to pre-pandemic norms1. It seems they view the health crisis as a disruptive influence – beyond its terrible death toll and economic and social impact.
Indeed, many conveniences borne of necessity during the pandemic (such as working from home, grocery deliveries, and digital health visits) have found favor with consumers and will likely continue to some extent post pandemic. In-home visits from clinical nurse educators, also called “nurse ambassadors,” is yet another service that’s come to the forefront during the pandemic and is an amenity that’s not likely to recede even when the virus does.
Patients’ feedback on such support has been overwhelmingly positive. One patient wrote: “This treatment has literally given me my life back and working with the nurse educator made me feel like I truly had someone to turn to with any questions, and they took care of everything. Thank you for this ground-breaking treatment and your dedication to patients dealing with their physically and emotionally debilitating disease.”
When patient education is needed most
- Indication is new
- Therapy/device is novel
- Dosing/self-administration is complex
- Treatment regimen is long-term and overwhelming
- Adverse events are expected
- REMS programs are underway
- Value must be demonstrated
- Patients have comorbidities
- Behavioral changes are required
- Patient discontinuation is high
A patient-centric commercial model
Deploying nurse educators is a way to align your resources with your goal of improving patient outcomes, rather than merely increasing share of voice. IQVIA’s nurse educators are highly experienced and well-trained professionals who visit patients face-to-face. Because of this, they tend to have instant credibility with their patients as they intrinsically understand the patient journey. Successful programs are able to
- Identify and address patients’ knowledge gaps
- Bolster the patient’s motivation to initiate therapy and continue treatment regimens
- Foster positive health behavior
IQVIA’s nurses are drawn from a national network of 2,200 clinical professionals who have all been carefully selected and trained so that they can be deployed in as little as two weeks.
Per-diem engagement
Life sciences companies can also now engage nurse educators on a per-diem basis rather than having to maintain a dedicated staff with fixed costs. This outsourcing approach allows you to “pay for what you use.” The resources assigned to your program can be scaled up or down as needed and can be secured as one component in a comprehensive patient support program or as a stand-alone service.
Outsourcing the nurse educator role doesn’t mean giving up all control; first, you can request nurses who are best suited to the assignment based on several criteria, including demographics, licenses, certifications, training, experience, and work history. Second, you have transparency into the team’s productivity and activities with customized dashboards that measure everything from expenses to impact by nurse and region.
The clinical nurse resources you need to support patient adherence and improve patient health outcomes are now available nearly on-demand; you can contract who you need, when you need them without absorbing fixed costs. The model is a win-win for patients, manufacturers, and the broader healthcare system. To learn more, contact us.
1 Survey conducted by Ipsos, reported here
Overcoming barriers to treatment with a clinical network
Read the facts about deploying a remote phlebotomy service to help patients start — and stay — on therapies.